[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346496-105":59,"doc-detail-346496-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","changes-in-egfr-activity-following-crisprcas9-editing-of-the-egf-binding-domain","Changes in EGFR activity following CRISPR/Cas9-editing of the EGF binding domain","","Elevated Epidermal Growth Factor Receptor (EGFR) expression is common in cervical cancer and is linked to poor clinical outcomes, yet existing EGFR-targeted therapies show limited efficacy. To isolate EGFR function from Epidermal Growth Factor (EGF) interactions, key ligand-binding-site amino acids were removed using CRISPR/Cas9. EGFR mutant cell lines were generated, sequenced, and characterized, showing that substitutions L14R and Y45M disrupt EGF binding and alter EGFR distribution. Y45M alone reduced binding without changing localization, with decreased EGFR mRNA and protein in mutants. Genome-wide profiling confirmed intended edits with no off-target CRISPR/Cas9 mutations, while spontaneous variants affecting phenotypes were detected.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/changes-in-egfr-activity-following-crisprcas9-editing-of-the-egf-binding-domain/346496/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/changes-in-egfr-activity-following-crisprcas9-editing-of-the-egf-binding-domain/346496.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is EGFR an important target in cervical cancer?","Question",{"text":112,"@type":113},"EGFR is overexpressed in most cervical cancers and correlates with poor prognosis. This is one reason EGFR-targeted approaches have been pursued, despite limited clinical efficacy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study separate EGFR function from EGF–EGFR interaction?",{"text":117,"@type":113},"The researchers used CRISPR/Cas9 to remove key amino acids from EGFR’s ligand-binding site, generating EGFR mutant cell lines to test the consequences of disrupting EGF binding.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main effects of the L14R and Y45M substitutions?",{"text":121,"@type":113},"The pair of substitutions L14R and Y45M within EGFR Domain I completely disrupted EGF binding and changed EGFR subcellular distribution. EGFR mRNA and protein levels were also decreased in mutant clones.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346496,1790180543,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nChanges in EGFR activity following CRISPR/Cas9-editing of the EGF binding domain  \nJelena Popović1, Anna Hahut1, Gabriel E. Torres1, Andrew Vincent1,  \nNashaly Soto-Echevarria1,3, Brian Wray2, Elizabeth T. Bartom2, Tatjana Paunesku1, Chelain R. Goodman1,4 & Gayle E. Woloschak1,5􀀍  \nElevated Epidermal Growth Factor Receptor (EGFR) expression is observed in most cervical cancers, and it is frequently associated with poor clinical outcomes. The limited efficacy of existing EGFRtargeted therapies in cervical cancer highlights the need for a deeper understanding of EGFR role in this cancer type. To investigate EGFR separately from its interaction with Epidermal Growth Factor (EGF), we removed the key amino acids from the ligand bindings site. We used CRISPR/Cas9 genome editing to generate a panel of EGFR mutant cell lines and then sequenced and characterized them in detail. Studying the phenotypes of mutant cell clones, we show that a pair of amino acid substitutions L14R andY45M within Domain I of EGFR protein completely disrupts EGF binding and changes EGFR subcellular distribution. A single substitution Y45M significantly reduced EGF binding but did not lead to subcellular redistribution of EGFR. Upon editing, EGFR mRNA and protein expression were decreased in mutant clones compared to wild type cells. Genome wide profiling of different CRISPR/ Cas9 clones confirmed correct editing of EGFR with no off target CRISPR/Cas9 generated mutations. Atthe same time, spontaneous mutations that could impact cell phenotypes were detected in mutant clones. Disruption of ligand binding domain of EGFR by sequential knockin CRISPR/Cas9 genome editing altered subcellular localization and phosphorylation of EGFR in cervical cancer cells. The results presented here provide insights that may accelerate the development of CRISPR/Cas9-based therapies for EGFR-dependent cancers and reinforce the importance of thorough evaluation of CRISPR/Cas9-generated phenotypes.  \nKeywords CRISPR-Cas9, EGFR, EGF binding, Cervical cancer, ME180  \nCervical cancer is the fourth most common cancer in women worldwide, with around 660,000 new cases and around 350,000 deaths in 2022. Overexpression of Epidermal Growth Factor Receptor (EGFR/ERBB1/HER1) is detected in approximately 90% of cervical cancers1–4, and is correlated with poor prognosis5. This overexpression is influenced by several pathways controlled by human papillomavirus (HPV) proteins6,7 which are nearly ubiquitous in cervical cancers. Notably, only 1.34% of cervical tumors harbor EGFR mutations ([https://www.my](https://www.my)[ ](https://www.my)[cancergenome.org/content/gene/egfr/](cancergenome.org/content/gene/egfr/ 8 indicating that)[ 8](cancergenome.org/content/gene/egfr/ 8 indicating that)[ indicating that](cancergenome.org/content/gene/egfr/ 8 indicating that) the majority exhibit wild-type EGFR.  \nEGFR is a transmembrane receptor tyrosine kinase important for cell division, survival, and differentiation9. Cervical cancer cells have been shown to express over 1,000,000 EGFR molecules per cell – far exceeding the 40,000 to 100,000 typically demonstrated in normal cells10. EGFR activation is triggered by various ligands11, 12. Seven known ligands bind to EGFR with different affinities and activate its downstream signaling: epidermal growth factor (EGF), transforming growth factor-alpha (TGF-α), heparin-binding EGF-like growth factor (HBEGF), betacellulin (BTC), amphiregulin (AREG), epiregulin (EREG), and epigen (EPGN) . EGF, TGF-α, HBEGF, and BTC are considered to be high-affinity, whereas AREG, EREG, and EPGN are considered lowaffinity ligands13. While EGFR demonstrates considerable ligand binding promiscuity14, its ligand molecule EGF  \n1Department of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. 2The LouisA Simpson and Kimberly K Querrey Biomedical Research Center, North","cbCaihWqk5xfO0Mo","https://ap.wps.com/l/cbCaihWqk5xfO0Mo","pdf",5599841,23,"English","# Abstract\n# EGFR in cervical cancer and need for targeted study\n## EGFR overexpression and mutation prevalence\n# CRISPR/Cas9 strategy to disrupt EGF binding\n## Generation and validation of EGFR mutant cell lines\n# Effects of ligand-binding domain edits on EGFR function\n## EGF binding, subcellular distribution, and phosphorylation\n## Changes in EGFR mRNA and protein expression\n## Off-target assessment and spontaneous mutations\n# Implications for CRISPR/Cas9-based therapies","[{\"question\":\"Why is EGFR an important target in cervical cancer?\",\"answer\":\"EGFR is overexpressed in most cervical cancers and correlates with poor prognosis. This is one reason EGFR-targeted approaches have been pursued, despite limited clinical efficacy.\"},{\"question\":\"How did the study separate EGFR function from EGF–EGFR interaction?\",\"answer\":\"The researchers used CRISPR/Cas9 to remove key amino acids from EGFR’s ligand-binding site, generating EGFR mutant cell lines to test the consequences of disrupting EGF binding.\"},{\"question\":\"What were the main effects of the L14R and Y45M substitutions?\",\"answer\":\"The pair of substitutions L14R and Y45M within EGFR Domain I completely disrupted EGF binding and changed EGFR subcellular distribution. EGFR mRNA and protein levels were also decreased in mutant clones.\"}]","Changes in EGFR activity following CRISPR/Cas9-editing of the EGF binding domain | PDF",1790061708,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3511465d62b5cc7dc5961e4f53762a0.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/90c22ce7d5de6d26ab15ac28d8cdf82b.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/334ab64b15713d59429220d4c6094c37.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/232c173291a42ab7c468bcfb9e238c3f.webp",980,1287]